Sharps Technology Ebitda Over Time
| STSS Stock | USD 3.53 0.06 1.73% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sharps Technology Performance and Sharps Technology Correlation. Sharps |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sharps Technology. If investors know Sharps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sharps Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.24) | Return On Assets (0.52) | Return On Equity (1.03) |
The market value of Sharps Technology is measured differently than its book value, which is the value of Sharps that is recorded on the company's balance sheet. Investors also form their own opinion of Sharps Technology's value that differs from its market value or its book value, called intrinsic value, which is Sharps Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sharps Technology's market value can be influenced by many factors that don't directly affect Sharps Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sharps Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sharps Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sharps Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Sharps Technology and related stocks such as JIN MEDICAL INTERNATIONAL, Meihua International, and G Medical Innovations Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZJYL | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 2.8 M | 3.2 M | 3.1 M | 3.4 M | 3.1 M | 2.8 M |
| MHUA | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 24 M | 25.9 M | 16.1 M | 15.8 M | 16.3 M |
| GCTK | (1.2 M) | (2.3 M) | (2.7 M) | (3 M) | (3.6 M) | (5.9 M) | (5.6 M) | (10.5 M) | (6.5 M) | (3.5 M) | (3.1 M) | (4 M) | (4.4 M) | (7.1 M) | (6.7 M) |
| LUCY | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (762.2 K) | (3.2 M) | (5.5 M) | (6.6 M) | (6.2 M) |
| NXGL | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (653 K) | (1.6 M) | (1.9 M) | (2.2 M) | (2.2 M) | (3.1 M) | (2.7 M) | (2.9 M) |
| AVGR | (33.1 M) | (33.1 M) | (33.1 M) | (35.5 M) | (25 M) | (40.6 M) | (50.6 M) | (39.4 M) | (22.1 M) | (18.5 M) | (16.4 M) | (17.4 M) | (15.8 M) | (16.3 M) | (17.2 M) |
| MBOT | (6.2 M) | (33 M) | (21.1 M) | (31.7 M) | (30.9 M) | (36.6 M) | (9.9 M) | (3.2 M) | (7.2 M) | (7.2 M) | (9 M) | (11.3 M) | (13.2 M) | (10.6 M) | (11.2 M) |
| POCI | 300 K | (1.3 M) | (1.2 M) | (1.2 M) | (1.3 M) | (1.1 M) | (970.3 K) | (321.4 K) | (445.9 K) | (1.3 M) | 50.2 K | (526.6 K) | (427.8 K) | (2.5 M) | (2.4 M) |
| KRMD | (546.3 K) | 1.4 M | 1.3 M | 1.2 M | 1.4 M | 1.4 M | (432.7 K) | 1.5 M | 3.3 M | 7.7 M | 1.6 M | (6.6 M) | (10.2 M) | (9.4 M) | (8.9 M) |
| INFU | (24.5 K) | 10.3 M | 10.3 M | 14.2 M | 15.5 M | 17.1 M | 11.7 M | 9.6 M | 11.7 M | 15.8 M | 22.8 M | 17.2 M | 15.1 M | 16.6 M | 11.4 M |
| UTMD | 1.1 M | 14.6 M | 15.2 M | 18 M | 25 M | 24.2 M | 23.7 M | 21.8 M | (18.7 M) | 17.6 M | 20.9 M | 26.2 M | 26.9 M | 24.8 M | 14.4 M |
| MLSS | (2.1 M) | (991.5 K) | (596.2 K) | 268.2 K | (1.6 M) | (3 M) | (6.4 M) | (4.7 M) | (4 M) | (106.9 K) | (7.4 M) | (7.3 M) | (8.7 M) | (7 M) | (6.6 M) |
Sharps Technology and related stocks such as JIN MEDICAL INTERNATIONAL, Meihua International, and G Medical Innovations Ebitda description
My Equities
My Current Equities and Potential Positions
| Sharps Technology | STSS |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.53
Additional Tools for Sharps Stock Analysis
When running Sharps Technology's price analysis, check to measure Sharps Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sharps Technology is operating at the current time. Most of Sharps Technology's value examination focuses on studying past and present price action to predict the probability of Sharps Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sharps Technology's price. Additionally, you may evaluate how the addition of Sharps Technology to your portfolios can decrease your overall portfolio volatility.